| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/27/2011 | EP2315031A1 Method for the differentiation between patients with active ulcerative colitis and patients in remission by detecting volatile organic compounds in exhaled air. |
| 04/27/2011 | EP2315030A1 Method for the differentiation between patients with active Crohn's disease and patients in remission by detecting volatile organic compounds in exhaled air. |
| 04/27/2011 | EP2315029A1 Method for the differentiation between Crohn's disease and ulcerative colitis by detecting volatile organic compounds in exhaled air. |
| 04/27/2011 | EP2315028A1 PODXL protein in colorectal cancer |
| 04/27/2011 | EP2315027A1 Substrates for isolating, reacting and microscopically analyzing materials |
| 04/27/2011 | EP2315026A2 Taxol immunoassay |
| 04/27/2011 | EP2315025A1 Method for the diagnosis of Inflammatory Bowel Disease by detecting volatile organic compounds in exhaled air. |
| 04/27/2011 | EP2315024A1 A method of quickly determining human abo/rh/mn blood type and a test kit thereof |
| 04/27/2011 | EP2315023A1 Process for quantitative determination of emissions, consisting of particulate matter, from surfaces of flexible sheet-like materials and device therefore |
| 04/27/2011 | EP2315017A1 Method for detection of fibromyalgia |
| 04/27/2011 | EP2315015A1 Analysis device by capillary electrophoresis method |
| 04/27/2011 | EP2315007A2 Light guide test sensor for use in determining an analyte in a fluid sample and methods of manufacturing the same |
| 04/27/2011 | EP2315000A2 Methods and apparatus to determine phase-change pressures |
| 04/27/2011 | EP2314716A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/27/2011 | EP2314713A1 Oligonucleotide probe, and use thereof |
| 04/27/2011 | EP2314712A1 Expression vectors encoding epitopes of antigens and methods for their design |
| 04/27/2011 | EP2314697A1 Streptococcus pneumoniae proteins and nucleic acids |
| 04/27/2011 | EP2314695A2 Ligand for receptor activator of NF-kappa B, ligand is member of TNF superfamily |
| 04/27/2011 | EP2314691A2 Fuctional and hyperfunctional siRNA |
| 04/27/2011 | EP2314686A1 Cells producing antibody compositions |
| 04/27/2011 | EP2314685A1 Cells producing antibody compositions |
| 04/27/2011 | EP2314684A1 Fluorescent protein and chromoprotein |
| 04/27/2011 | EP2314683A1 Fluorescent protein and chromoprotein |
| 04/27/2011 | EP2314682A2 Fluorescent protein |
| 04/27/2011 | EP2314681A1 Modified biotin-binding protein |
| 04/27/2011 | EP2314676A1 Compositions and methods for the treatment of immune related diseases |
| 04/27/2011 | EP2314629A1 Recombinant production of mixtures of antibodies |
| 04/27/2011 | EP2314628A1 Anti-cd27 antibody |
| 04/27/2011 | EP2314621A1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/27/2011 | EP2314620A1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/27/2011 | EP2314612A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314611A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314610A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314597A1 Kit and method for the labelling of biomolecules |
| 04/27/2011 | EP2314376A1 Test sensor and method for manufacturing the same |
| 04/27/2011 | EP2314314A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 04/27/2011 | EP2314217A1 Method and device for fast measurement of frequency response with scalable short chirp signals |
| 04/27/2011 | EP2313850A2 Automatic information transfer by color encoded fields |
| 04/27/2011 | EP2313785A1 A method and assembly for measuring thrombin generation in plasma |
| 04/27/2011 | EP2313784A1 Immunotherapeutic method |
| 04/27/2011 | EP2313783A2 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
| 04/27/2011 | EP2313782A1 Proteomic fingerprint for the diagnosis of non-alcoholic steatohepatitis (nash) and/or steatosis |
| 04/27/2011 | EP2313781A1 Methods and kit for analyte detection |
| 04/27/2011 | EP2313780A1 Phosphorylated c-erbb2 as a superior predictive theranostic marker for the diagnosis and treatment of cancer |
| 04/27/2011 | EP2313779A2 Use of defensin alpha 1 and/or defensin alpha 4, as a marker for predicting treatment response and/or a relapse in a patient suffering from chronic myeloid leukaemia |
| 04/27/2011 | EP2313778A1 Diagnostics for membranous nephropathy |
| 04/27/2011 | EP2313777A1 A method of characterizing antibodies |
| 04/27/2011 | EP2313776A1 Immunoassay for detection of neurotoxic amino acid associated with neurological disorders |
| 04/27/2011 | EP2313775A2 In situ lysis of cells in lateral flow immunoassays |
| 04/27/2011 | EP2313774A1 High throughput system for cfu assay by the use of high resolution digital imaging, differential staining and automated laboratory system |
| 04/27/2011 | EP2313773A1 Means and methods diagnosing gastric bypass and conditions related thereto |
| 04/27/2011 | EP2313771A2 System and method for collecting plasma protein fractions from separated blood components |
| 04/27/2011 | EP2313770A2 Multi-sample particle analyzer system and method for high throughput screening |
| 04/27/2011 | EP2313769A1 5-ht6 receptor and modulators thereof for the treatment of insulin-related disorders |
| 04/27/2011 | EP2313768A1 Determination of the hydrodynamic radii and/or content of constituents of a mixture by analysis of the taylor dispersion of the mixture in a capillary tube |
| 04/27/2011 | EP2313767A1 Cuvette-based apparatus for blood coagulation measurement and testing |
| 04/27/2011 | EP2313761A1 Systems and methods for optical measurement of analyte concentration |
| 04/27/2011 | EP2313760A1 Diode laser device for the non-invasive measurement of glycaemia |
| 04/27/2011 | EP2313759A1 Method and system for biofouling control of shipboard components |
| 04/27/2011 | EP2313756A1 Reaction device for analyzing biological samples and relative method |
| 04/27/2011 | EP2313755A1 Device and method for the automatic detection of biological particles |
| 04/27/2011 | EP2313528A2 Methods for the cytological analysis of cervical cells |
| 04/27/2011 | EP2313507A2 High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein |
| 04/27/2011 | EP2313504A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 04/27/2011 | EP2313437A1 Cancerous disease modifying antibodies |
| 04/27/2011 | EP2313425A2 Inorganic-binding peptides and quality control methods using them |
| 04/27/2011 | EP2312943A2 Method and kit for assessing viable cells |
| 04/27/2011 | EP2167630B1 Method for analysing the effect of a gaseous medium on a biological test system using an extracellular metabolisation system and device for carrying out said method |
| 04/27/2011 | EP2039367B1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 04/27/2011 | EP1957988B1 Systems and methods for measuring glycated hemoglobin |
| 04/27/2011 | EP1685386B1 Reaction monitoring of chiral molecules using fourier transform infrared vibrational circular dichroism spectroscopy |
| 04/27/2011 | EP1578959B1 Immunizing fish against viral infection |
| 04/27/2011 | EP1539233B1 Super humanized antibodies |
| 04/27/2011 | EP1532174B1 Anti-igf-i receptor antibody |
| 04/27/2011 | EP1512011B1 Solid phase substrate for immobilizing biomolecules |
| 04/27/2011 | EP1461619B1 Improved structured-functional bonding matrices for biomolecules |
| 04/27/2011 | EP1444514B1 Device for measuring compounds in body liquids |
| 04/27/2011 | EP1432446B1 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation |
| 04/27/2011 | EP1419175B1 Replikin peptides and uses thereof |
| 04/27/2011 | CN201811963U Reverse colloidal gold-immunochromatography combined test plate |
| 04/27/2011 | CN201811962U Portable urine glucose detector |
| 04/27/2011 | CN201811961U Flushing capacity test device |
| 04/27/2011 | CN201811960U Detector of water content of crude oil capable of realizing on-line wax removal |
| 04/27/2011 | CN201811959U Flaw detection box |
| 04/27/2011 | CN201811958U Pollution-free water quality testing meter |
| 04/27/2011 | CN201811957U Manual ultrahigh pressure food performance detector |
| 04/27/2011 | CN201811956U Artificial board formaldehyde release tester by catharometry |
| 04/27/2011 | CN201811955U Car volatile organic compounds (VOC) release amount test environmental chamber |
| 04/27/2011 | CN201811954U Environmental box for testing released quantity of harmful substances in furniture |
| 04/27/2011 | CN201811953U Multifunctional air quality detector |
| 04/27/2011 | CN201811952U Experimental apparatus for simulating chemical huff and puff of oil well |
| 04/27/2011 | CN201811951U Toxicity test device for fume generated by burning materials |
| 04/27/2011 | CN201808459U Expired gas alcoholicity detecting lock with fingerprint identification system |
| 04/27/2011 | CN201807225U Urine separating and enriching device |
| 04/27/2011 | CN201807053U Face mask capable of being externally connected with carbon dioxide consistometer and easy for patients to inhale |
| 04/27/2011 | CN102037362A Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 04/27/2011 | CN102037361A Molecular diagnosis and classification of malignant melanoma |
| 04/27/2011 | CN102037360A Oral care methods and systems |
| 04/27/2011 | CN102037359A Method for evaluation of function of phagocyte |
| 04/27/2011 | CN102037358A Methods for assessing the results of disc-based bioassays with standard computer optical drives |